Rafferty Asset Management, LLC Ptc Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 100,460 shares of PTCT stock, worth $3.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

100,460

Previous 294,304 65.87%

Holding current value

$3.78 Million

Previous $8.56 Million 64.12%

% of portfolio

0.01%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.69 - $40.12 $4.79 Million - $7.78 Million	-193,844 Reduced 65.87%	100,460 $3.07 Million
Q1 2024 May 13, 2024	SELL	$24.15 - $31.95 $1.1 Million - $1.46 Million	-45,659 Reduced 13.43%	294,304 $8.56 Million
Q4 2023 Feb 13, 2024	BUY	$18.07 - $29.37 $2.42 Million - $3.93 Million	133,676 Added 64.8%	339,963 $9.37 Million
Q3 2023 Nov 13, 2023	BUY	$22.41 - $41.99 $295,184 - $553,092	13,172 Added 6.82%	206,287 $4.62 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $1.44 Million - $2.11 Million	35,672 Added 22.66%	193,115 $7.85 Million
Q1 2023 May 11, 2023	SELL	$38.16 - $48.86 $2.06 Million - $2.64 Million	-54,007 Reduced 25.54%	157,443 $7.63 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $2.76 Million - $4.51 Million	82,292 Added 63.71%	211,450 $8.07 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $318,311 - $409,583	7,606 Added 6.26%	129,158 $6.48 Million
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $968,652 - $1.71 Million	-37,838 Reduced 23.74%	121,552 $4.87 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $574,509 - $768,770	17,237 Added 12.13%	159,390 $5.95 Million
Q4 2021 Feb 10, 2022	BUY	$35.36 - $41.86 $2.22 Million - $2.62 Million	62,662 Added 78.83%	142,153 $5.66 Million
Q3 2021 Nov 10, 2021	BUY	$37.01 - $44.74 $694,085 - $839,053	18,754 Added 30.88%	79,491 $2.96 Million
Q2 2021 Aug 10, 2021	BUY	$37.95 - $49.37 $141,667 - $184,298	3,733 Added 6.55%	60,737 $2.57 Million
Q1 2021 May 10, 2021	BUY	$46.8 - $68.92 $2 Million - $2.94 Million	42,657 Added 297.32%	57,004 $2.7 Million
Q4 2020 Feb 10, 2021	SELL	$47.96 - $67.64 $1.4 Million - $1.97 Million	-29,166 Reduced 67.03%	14,347 $876,000
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $1.1 Million - $1.38 Million	24,122 Added 124.4%	43,513 $2.03 Million
Q2 2020 Aug 07, 2020	BUY	$42.56 - $54.98 $526,084 - $679,607	12,361 Added 175.83%	19,391 $984,000
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $1.7 Million - $3.12 Million	-52,623 Reduced 88.22%	7,030 $314,000
Q4 2019 Feb 10, 2020	SELL	$32.22 - $50.07 $959,221 - $1.49 Million	-29,771 Reduced 33.29%	59,653 $2.87 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $368,232 - $524,474	-10,888 Reduced 10.85%	89,424 $3.02 Million
Q2 2019 Aug 09, 2019	SELL	$35.42 - $45.0 $345,486 - $438,930	-9,754 Reduced 8.86%	100,312 $4.51 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $3.09 Million - $4.35 Million	110,066 New	110,066 $4.14 Million

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Ptc Therapeutics, Inc. Transaction History